You are here: Home Courses & Events Lecture series "Career & …

Career & Development

Wednesday, 11-12 c.t., lecture hall pharmacy, Hermann-Herder-Str. 7, 79104 Freiburg

Winter term 2023/24

  • 25.10.2023
    Jörg Zimmermann, Vice President Vetter Development Service, External Affairs, Vetter Pharma, Ravensburg

  • 08.11.2023
    Dr. Katharina Gamerdinger, Senior Medical Manager & Dr. Daniela Fuchs, Senior Account Manager, Havas Life Bird & Schulte, Freiburg

  • 15.11.2023
    Dr. Jana Naue, Research group leader, Institut für Rechtsmedizin, Forensische Molekularbiologie, Freiburg

  • 22.11.2023
    Dr. Roland Frötschl, Project leader Unit Genetic and Reproductive Toxicology, BfArM, Federal Institute for Drugs and Medical Devices, Bonn

  • 29.11.2023
    Dr. Sonja Schallenberg, Group leader R&D, Miltenyi Biotec, Bergisch Gladbach

  • 06.12.2023
    Session cancelled.

 

  • 13.12.2023
    Dr. Désirée Popadić, Head of Production (Bulk Production), Losan Pharma, Neuenburg

  • 10.01.2024
    Dr. Janina Zimmermann, Product Managment/Sales Marketing, Endress + Hauser, Weil, Germany

  • 17.01.2024
    Dr. Michael Bscheider, Roche Pharma Research and Early Development Pharmaceutical Sciences (PS) / Investigative & Immuno Safety, Roche Innovation Center Basel

  • 24.01.2024
    Dr. Inga Schuster, Director Sterile Production, Takeda GmbH, Konstanz

  • 07.02.2024
    Dr. Fee Bengsch, Clinical Trial Manager, Dr. Falk Pharma, Freiburg

 

 

Winter term 2022/23

 

  • 19.10.2022:  Dr. Bernhard Loll, Group Leader and CEO, FU Berlin and moloX GmbH, Berlin
  • 26.10.2022:   Dr. Ekaterina Kuchmina, Lab leader, Spindiag, Freiburg
  • 02.11.2022:   Dr. Gesa Albert, Indication Lead Cardiology and Senior International Medical Affairs Manager, Roche Diagnostics International, Switzerland
  • 09.11.2022:   Dr. Anna Bauß, Quality&Compliance Specialist R&D, PTW, Freiburg
  • 16.11.2022:   Dr. Christian Ante, Mayor of Merzhausen, Merzhausen
  • 23.11.2022:   Dr. Hartmut Vodermaier, Senior Editor, The EMBO Journal, Wiley VCH, Frankfurt
  • 30.11.2022:   Dr. Alejandro Gomez Auli, Postdoc, proteomics facility, Max Planck institute of immunobiology and epigenetics, Freiburg
  • 07.12.2022:  Dr. Tresfore Dambe, Clinical Trial Supply Manager, department Global Clinical Supplies, Novartis, Basel
  • 14.12.2022:   Dr. Andreas Schmidt, Senior Manager International Communications, Merck Group, Darmstadt
  • 21.12.2022:   Prof. Dr. Ansgar Pommer, CSO/ Professor, SkinSysTec/ University of Applied sciences, Cologne
  • 11.01.2023:   Dr. Fabienne Praxmarer, Scientist R&D, Losan, Neuenburg
  • 18.01.2023:   Dr. Vladimir Kirkin, Senior Director/Development Project Leader, Molecular Partners, Zurich
  • 25.01.2023:   Dr. Eliza Leusmann, Editor Scientific Magazine, GDCh, Marburg
  • 01.02.2023:   Dr. Inga Schuster, Director Sterile Production, Takeda GmbH, Konstanz

Winter term 2021/22

 

  • 03.11.2021:   Kristina Semukhina, Novartis Pharma AG, Basel
  • 10.11.2021:   Dr. Tobias Mück, Sanofi, Wiesbaden
  • 17.11.2021:   Dr. Martin Roatsch, Deutsche Forschungsgemeinschaft (DFG), Bonn
  • 24.11.2021:   Dr. Nadine Göhring, Eurofins GeneScan Technologies, Freiburg
  • 01.12.2021:   Dr. Tatjana Gust, Bayer AG, Berlin - online -
  • 08.12.2021:   PD Dr. Klaus-Peter Knobeloch, Institute of Neuropathology, University of Freiburg - online -
  • 15.12.2021:   Dr. Stephan Schilling, Fraunhofer Institute for Cell Therapy and Immunology, Halle  (Saale) - online -
  • 12.01.2022:   Dr. Britta Wallmen, Arbeitskreis Klinische  Prüfungen, PD Dr. med. Seiler GmbH, Freiburg - online -
  • 19.01.2022:   Dr. Raphael Vogler, ChemCon, Freiburg - online -
  • 26.01.2022:   Dr. Christine Koslowski, Endress & Hauser, Weil am Rhein - online -
  • 02.02.2022:   Dr. Christine Geisler-Kuhl, Bristol Myers Squibb, Berlin - online -
  • 09.02.2022:   Dr. Daniel Teufel, Boehringer Ingelheim, Biberach - online -

Winter term 2020/21 - online lecture

 

  • 25.11.2020:   Dr. Roman Simon, Boehringer Ingelheim Pharma GmbH&Co KG, Biberach
  • 13.01.2021:   Dr. Waltraut Mossmann, McKinsey&Company Inc., Switzerland
  • 27.01.2021:   Dr. Heinrich Schell, AstraZeneca GmbH, Wedel
  • 03.02.2021:   Dr. David Zhang, Roche Pharmaceutical Research and Early Development, Basel
  • 10.02.2021:   Dr. Marija Marolt, PRA Health Sciences, Munich

 

Winter term 2019/20

 

  • 23.10.2019:   Dr. Simon Netzer, Pharmaplan AG, Basel, Switzerland
  • 30.10.2019:   Dr. Martin Braun, Schwabe GmbH & Co KG, Karlsruhe
  • 06.11.2019:   Dr. Thilo Kaltenbach, Roland Berger Consulting, München
  • 13.11.2019:   Dr. Stefan Eschbach, Management Consulting, Stegen 
  • 20.11.2019:   Dr. Jürgen Kaselowski, SAS Institute GmbH, Heidelberg
  • 27.11.2019:   Dr. Gerald Pratsch, LKA Baden-Württemberg
  • 18.12.2019:   Dr. Dominic Birth, Straumann Deutschland, Freiburg
  • 08.01.2020:   Dr. Florian Hubrich, ETH Zürich
  • 22.01.2020:   Markus Schlegel, IKA-Werke GmbH & Co. KG, Staufen
  • 29.01.2020:   Dr. Sebastian Fuchs, Roche Pharma AG, Basel, Switzerland
  • 05.02.2020:   Dr. Anna Bauß, Storz GmbH & Co. KG, Kenzingen
  • 12.02.2020:   Dr. Nikola Schwarzer, Bernstein Coordination Site, Außenstelle Forschungszentrum Jülich

Winter term 2018/19

 

  • 24.10.2018:   Dr. Andreas Müller, Chromgrün, Planungs- und Beratungs-GmbH Co. KG, Velbert
  • 31.10.2018:   Dr. Alexandra Franzke, Science Support Center der Universität Freiburg
  • 07.11.2018:   Christina Meinert, bts, Biotechnologische Studenteninitiative
  • 14.11.2018:   Dr. Achim Grube, Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach
  • 21.11.2018:   Dr. Eike Bergner, Hoffmann-La Roche AG, Global Manufacturing Science & Technology, Basel
  • 28.11.2018:   Dr. Helmut Laaff, TPL Path Labs, Freiburg
  • 05.12.2018:   Dr. Barbara Pauly, Human Frontier Science Program Organization, Strasbourg
  • 12.12.2018:   Prof. Stefan Pelzer, Evonik Nutrition & Care GmbH, Halle
  • 19.12.2018:   Dr. Volker Lorbach, ISERA GmbH, Düren
  • 09.01.2019:   Dr. Frank Rauschen, Novartis Pharma AG, Basel
  • 16.01.2019:   Dr. Matthias Göbel, AstraZeneca GmbH, Wedel
  • 23.01.2019:   Dr. Christopher Bangert, Deutscher Caritasverband e.V., Referat Sozialwirtschaft
  • 30.01.2019:   Dr. Christine Koslowski, Patentanwältin, Endress & Hauser


Winter term 2017/18

 

  • 18.10.2017: Dr. Eva Oswald, Lab Head Cellular Science, Charles River, Freiburg
  • 25.10.2017: Dr. Carolin von Schoultz, Scientific officer, LS2 Life Sciences Switzerland, Bern
  • 08.11.2017: Dr. Heiko Erhardt, Laboratory Scientist, Johnson & Johnson MEDICAL GmbH
  • 15.11.2017: Dr. Thomas Steinbrecher, Senior Applications Scientist, Schrödinger GmbH, Germany
  • 22.11.2017: Dr. Katharina Rauch, Management Start Up Medical Functions, Roche Pharma AG, Grenzach
  • 29.11.2017: Dominik Walther, Apotheker ohne Grenzen
  • 06.12.2017: Jun.-Prof. Dr. Jennifer Andexer, Institute of Pharmaceutical Sciences, University Freiburg
  • 20.12.2017: Dr. Robert Neugebauer, Pharmaceutical Development Leader, Elanco Deutschland, Bad Homburg
  • 10.01.2018: Dr. Laura van Niftrik, Assistant Professor at Radboud University, Nijmegen, NL
  • 17.01.2018: Dr. Heinrich Schell, Clinical Liaison Manager Oncology, Lilly Deutschland, Bad Homburg
  • 31.01.2018: Dr. Jochen Rupp, Senior Product Manager Labordiagnostik, Bosch Healthcare Solutions, Waiblingen

 

Winter term 2016/17

 

  • 19.10.2016:    Dr. Kurt Wilhelm Stahl, Waisenmedizin e.V. Freiburg, Germany
  • 26.10.2016:    Dr. Michael Breuer, BASF SE, Ludwigshafen, Germany
  • 02.11.2016:    Dr. Eduard Frick, Sigma-Aldrich Production GmbH, Buchs, Switzerland
  • 09.11.2016:    Dr. Helen Potter, Royal Society of Chemistry (RSC), Cambridge, United Kingdom
  • 16.11.2016:    Dr. Martin Schulte, Syngenta Agro GmbH, Maintal, Germany
  • 23.11.2016:    Dr. Jens Fuchser, Bruker Daltonik GmbH, Bremen, Germany
  • 30.11.2016:    Dr. Stefanie Bold, Novartis, Pharma AG, Basel, Switzerland
  • 07.12.2016:    Dr. Marius Löppenberg, MSD, Haar, Germany
  • 18.01.2017:    Dr. Richard Pauptit, Associate Director and Senior Principal Scientist, AstraZeneca, UK (retired)
  • 25.01.2017:    Dr. Patrick Chène, Director, Head of Biochemistry, Oncology Department, Novartis, Switzerland
  • 01.02.2017:    Dr. Dennis A. Effertz, Abrechnungszentrum Emmendingen, Germany